This association has not been previously explored in MDS meanwhile, in solid tumors TERT mutations were associated with significant poor clinical parameters which predict poor prognosis and may represent a novel therapeutic target (Shimoi et al., 2018). Here, TERT is linked to myelodysplastic syndrome.